[Co-Yea Biotech] February 2026 Monthly Revenue: NT$ 0.55 Billion (YoY +0.1%)
Co-Yea Biotech (1786), a biotechnology and medical enterprise, announced its February 2026 revenue report. The company's revenue for the month was NT$ 0.55 billion (NT$ 55,099 thousand), marking a slight year-on-year increase of 0.1%, maintaining relatively stable operational performance.
📋 Article Processing Timeline
- 📰 Published: February 1, 2026 at 09:00
- 🔍 Collected: April 7, 2026 at 08:00 (1559h 0m after Published)
- 🤖 AI Analyzed: April 8, 2026 at 00:18 (16h 18m after Collected)
Company Code: 1786
Company Name: Co-Yea Biotech
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month Revenue: NT$ 55,099 thousand (NT$ 0.55 billion)
YoY Change (Same Month Last Year): +0.1%
Company Name: Co-Yea Biotech
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month Revenue: NT$ 55,099 thousand (NT$ 0.55 billion)
YoY Change (Same Month Last Year): +0.1%
FAQ
What was Co-Yea Biotech's revenue for February 2026?
Co-Yea Biotech's revenue for February 2026 was NT$ 55,099 thousand, which is equivalent to NT$ 0.55 billion.
How did Co-Yea Biotech's February 2026 revenue compare to the same month last year?
Co-Yea Biotech's revenue in February 2026 showed a year-over-year increase of +0.1% compared to the same month in the previous year.
What is the company code for Co-Yea Biotech?
The company code for Co-Yea Biotech is 1786.
In which industry does Co-Yea Biotech operate?
Co-Yea Biotech operates within the Biotechnology and Medical Industry.
What was the exact revenue figure in thousands for Co-Yea Biotech in February 2026?
The exact revenue figure for Co-Yea Biotech in February 2026 was NT$ 55,099 thousand.